buyWeak

Louis C. Lucido bought $2,188 of BICX

Interim President at BioCorRx Inc.. 3,126 shares at an average of $0.70, traded Jan 12, 2024, filed Jan 17, 2024.

Conviction score

Value

$2,188

3,126 shares

Holdings after

474,933

+1% from before

From 52-week low

+4%

low $0.67, close $0.70

From 52-week high

-68%

high $2.22, as of Jan 12, 2024

Score components

Role
President
+20
Trade size
$2k at market
0
Relative to holdings
Under 1% of holdings (0.7%)
-5
Price context
4% above the 52-week low; 68% below the 52-week high
+18
Cluster
No other insider buying within 14 days
0
Repeat buying
First buy in 90 days
0
Track record
Too few past buys to judge (0 with prices)
0

What happened after comparable buys

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

This signal so far: 1m +21.4%, 3m +110.0%, 6m -25.7%.

Price around the trade, and since

From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.

BICXOct 12, 2026 · close 0.25

Since filing Jan 17, 2024: -64.3%SPY +70.1% · excess -134.4%

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™

Rows in this filing

Every transaction in Form 4 0001477932-24-000249, as filed. Open on EDGAR

Date	Transaction	Shares	Price	Value	Holdings after	Filed
Jan 12, 2024	POpen-market purchase Common Stock, par value $0.001	+3,000	$0.70	$2,100	474,807	Jan 17, 2024
Jan 16, 2024	POpen-market purchase Common Stock, par value $0.001	+126	$0.70	$88	474,933	Jan 17, 2024

Related signals

Other insiders at BioCorRx Inc. and this insider’s other filings.

Score	Company	Insider	Value	Holdings	Filed
36Weak	BICXbuy BioCorRx Inc.	Louis C. Lucido President	$4,170 5,000 shares	+6%	Dec 15, 2022
33Weak	BICXbuy BioCorRx Inc.	Louis C. Lucido President	$3,126 1,590 shares	+2%	Oct 11, 2022

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.